Fintech
BNPL PausePay Signs Deal with VISA, Prepares €1M Round
PausePay, Italy’s first BNPL solution for businesses, was developed with Allianz Trade and Visa, offering seamless payment deferrals via Visa’s global network. CEO Luca Scali aims for PausePay’s independent growth, following its success within CashInvoice. CashInvoice originated €880 million in credit in 2023, including €250 million through fintech solutions like BNPL, fostering strong corporate partnerships.
PausePay, an Italian fintech startup active in the Buy Now, Pay Later (BNPL) sector for businesses, founded in 2022 by Luca Scali, also founder of the CashInvoice platform, specialized in financing for SMEs, has signed an agreement with the digital payments giant VISA: the collaboration will allow customers to access a deferred payment system through a new business credit card model managed by PausePay and issued by VISA.
PausePay was the first BNPL solution in Italy dedicated to the business segment
Users of the BNPL PausePay service, which was developed in collaboration with Allianz Trade, a credit insurance giant that manages the entire credit assessment process, will therefore be able to defer payments quickly and easily, leveraging the global coverage of the VISA network, which on average invests 2 billion dollars every year to evolve the integrity and resilience of its network through artificial intelligence and machine learning.
Stefano M. Stoppani, country manager Visa Italia, commented: “This partnership confirms Visa’s constant commitment to digital payments innovation and the enhancement of the Italian fintech ecosystem. We are happy to make the benefits offered by our global network available to PausePay customers to better direct the value that this model is able to provide to businesses in our country.”
And Luca Scali, CEO of PausePay, added: “We are proud to collaborate with VISA to launch a solution that will innovate the way business customers can manage their purchases. This partnership combines our innovative BNPL platform with VISA’s experience, creating a totally innovative and once again first mover product, which perfectly meets the needs of our customers.”
PausePay was the first BNPL solution in Italy dedicated to the business segment, then followed by Opyn , another fintech lending platform for SMEs. The market opportunity seems very large. The online B2B transaction market in Europe is growing rapidly: with an estimated value of $1.84 trillion in 2021, it is expected to reach $11.26 trillion by 2030, with a CAGR of 22.3%.
PausePay was created as a project within CashInvoice, a fintech startup by Luca Scali, who then, together with his partners Daniele Fani and Giovanna Arcangeli , decided to transform it into a separate company, which now aims to grow independently and which, according to what BeBeez has learned , plans to raise a first seed round from investors of at least one million euros, between the end of 2024 and the beginning of 2025 .
In 2023 CashInvoice originated 880 million euros of credit, of which 250 million were disbursed through the fintech platform in the form of invoice trading, reverse factoring, tax credit transfer and Buy Now Pay Later (BNPL) dedicated to businesses, thanks to relationships with many sellers, including over a hundred large corporations, including multinationals.
CashInvoice, in spring 2023, had secured a 500 million euro business financing program from Fasanara Capital and as part of that agreement had sold 10% of the capital to Fasanara. To date, Scali, thanks to many years of experience with CashInvoice, has decided to focus on the new business with new strategic partners and new investors for funding support.
__
(Featured image by Aleksandrs Karevs via Unsplash)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Be Beez. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us
-
Impact Investing2 weeks ago
COP29: Everything Business Leaders Should Know
-
Biotech24 hours ago
Spanish Pharma Stocks Plummet 10% in November
-
Crypto2 weeks ago
Elon Musk, Donald Trump, and DOGE: Unraveling the Mystery Mission
-
Biotech1 week ago
The PCTEX in Badajoz, Spain, Will Host the ‘Biotech Conecta’ Event on December 10th